Effects of verapamil on etoposide pharmacokinetics after intravenous and oral administration in rats

No abstract is available for this paper.

• Publication year

  2008

• Venue

  European journal of drug metabolism and pharmacokinetics

• Publication date

  2008-07-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/BF03191113PMID 19007041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ABC Transporters in Microorganisms

  2010cited by this paper
• Inhibition of intestinal P-glycoprotein and effects on etoposide absorption

  2009cited by this paper
• Effects of morin on the pharmacokinetics of etoposide in rats.

  2007cited by this paper
• Pharmacokinetic interaction between verapamil and everolimus in healthy subjects.

  2005cited by this paper
• The ABCs of drug transport in intestine and liver: efflux proteins limiting drug absorption and bioavailability.

  2004cited by this paper
• Effect of cyclosporine A on the tissue distribution and pharmacokinetics of etoposide

  2004cited by this paper
• Role of P-Glycoprotein in Pharmacokinetics

  2003cited by this paper
• The Conduct of In Vitro and In Vivo Drug‐Drug Interaction Studies: A PhRMA Perspective

  2003cited by this paper
• Relative enzymatic activity, protein stability, and tissue distribution of human steroid-metabolizing UGT2B subfamily members.

  2001cited by this paper
• Effect of hydroxyzine on the transport of etoposide in rat small intestine

  2001cited by this paper
• A family of drug transporters: the multidrug resistance-associated proteins.

  2000cited by this paper
• P-glycoprotein transporters and the gastrointestinal tract: evaluation of the potential in vivo relevance of in vitro data employing talinolol as model compound.

  1998cited by this paper
• A study on the metabolism of etoposide and possible interactions with antitumor or supporting agents by human liver microsomes.

  1998cited by this paper
• O-demethylation of epipodophyllotoxins is catalyzed by human cytochrome P450 3A4.

  1994cited by this paper
• In vivo models of P-glycoprotein-mediated multidrug resistance.

  1994cited by this paper
• The expression of UDP-glucuronosyltransferases of the UGT1 family in human liver and kidney and in response to drugs.

  1993cited by this paper
• ABC transporters: from microorganisms to man.

  1992cited by this paper
• Stereoisomers of calcium antagonists which differ markedly in their potencies as calcium blockers are equally effective in modulating drug transport by P-glycoprotein.

  1992cited by this paper
• The Clinical Pharmacology of Etoposide and Teniposide

  1987cited by this paper
• Cytochrome P-450-mediated O-demethylation: a route in the metabolic activation of etoposide (VP-16-213).

  1987cited by this paper
• Stereoselective first-pass metabolism of highly cleared drugs: studies of the bioavailability of L- and D-verapamil examined with a stable isotope technique.

  1984cited by this paper
• [Clinical pharmacology].

  1968cited by this paper

• Adequate Formulation Approach for Oral Chemotherapy: Etoposide Solubility, Permeability, and Overall Bioavailability from Cosolvent- vs. Vitamin E TPGS-Based Delivery Systems.

  2021cites this paper
• Enhanced oral bioavailability of an etoposide multiple nanoemulsion incorporating a deoxycholic acid derivative–lipid complex

  2020cites this paper
• Influence of verapamil on the pharmacokinetics of oridonin in rats

  2019influential citation
• Effects of verapamil on the pharmacokinetics of puerarin in rats

  2019cites this paper
• Impact of Zn2+ on ABC Transporter Function in Intact Isolated Rat Brain Microvessels, Human Brain Capillary Endothelial Cells, and in Rat in Vivo.

  2018cites this paper
• The effects of verapamil on the pharmacokinetics of curculigoside in rats

  2016cites this paper
• Development of Novel lipid Nanoparticles for oral Bioavailability Enhancement of Irinotecan: In-vitro and In-vivo Investigations

  2015cites this paper
• OATP and MRP 2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human

  2014cites this paper
• OATP and MRP2-mediated hepatic uptake and biliary excretion of eprosartan in rat and human

  2014cites this paper
• Clinical Pharmacology in Pediatrics

  2014cites this paper
• Oral treatment with etoposide in small cell lung cancer – dilemmas and solutions

  2013cites this paper
• Self-nanoemulsifying lipid carrier system for enhancement of oral bioavailability of etoposide by P-glycoprotein modulation: in vitro cell line and in vivo pharmacokinetic investigation.

  2013cites this paper
• Etude de l’effet sur la P‐glycoprotéine (ABCB1) de deux médicaments dirigés contre le récepteur de facteur de croissance épithélial (EGFR), le cétuximab et le lapatinib et conséquence sur la pharmacocinétique et l’efficacité anti‐tumorale de médicaments substrats de ABCB1

  2013cites this paper
• Effects of morin on the pharmacokinetics of etoposide in 7,12-dimethylbenz[a]anthracene-induced mammary tumors in female Sprague-Dawley rats.

  2013cites this paper
• Comparison of human, mouse and rat ABC transporters on basis of their substrate and inhibitor profile

  2012cites this paper
• Cysteine effects on the pharmacokinetics of etoposide in protein–calorie malnutrition rats: increased gastrointestinal absorption by cysteine

  2011cites this paper
• Involvement of P-glycoprotein and CYP 3A4 in the enhancement of etoposide bioavailability by a piperine analogue.

  2011cites this paper
• Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin.

  2011cites this paper
• SIMPLE AND EFFICIENT HPLC-UV QUANTITATION OF ETOPOSIDE AND ITS CIS-ISOMER IN RAT MICRO-VOLUME PLASMA AND TISSUE SAMPLES: APPLICATION TO PHARMACOKINETIC AND BIODISTRIBUTION STUDIES

  2011cites this paper
• Molecular mechanisms of biliary excretion of cefditoren and the effects of cefditoren on the expression levels of hepatic transporters.

  2010cites this paper
• Simultaneous determination of etoposide and a piperine analogue (PA-1) by UPLC-qTOF-MS: evidence that PA-1 enhances the oral bioavailability of etoposide in mice.

  2010cites this paper
• Disposition of everolimus in mdr1a-/1b- mice and after a pre-treatment of lapatinib in Swiss mice.

  2009cites this paper